Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
| Website: | www.criver.com |
| Email: | askcharlesriver@crl.com |
| Main Phone: | +1 781 222-6000 |
| Address: | 251 Ballardvale Street |
| State: | MA |
| City / Town: | Wilmington |
| Country: | USA |
| Postal Code: | 01887 |
| Exchange: | NYE |
| CEO: | James C. Foster |
| Employees: | 11800 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
| Last Price 125.20 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid 121.00 | Bid Size 100.00 | Ask 137.80 | Ask Size 100.00 |
| Open N/A | High N/A | Low N/A | Prev Close 125.20 |
| Last Trade | Volume 0 | 52 Wk Hi 135.90 | 52 Wk Low 96.70 |
| Market Cap 6 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 48,032,375.00 | EPS (TTM) 2.64 | PE Ratio 47.40 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 41 | 1000 |
| Number of Buys | 18 | 61 |
| Number of Sells | 23 | 939 |
| Net Activity | 23262 | 64809 |
| Last 10 Buys | Shares |
|---|---|
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 129 | 129 | 129 | 129 |
| Low Target Price Estimate | 102 | 102 | 102 | 102 |
| Mean Target Price Estimate | 118.25 | 118.25 | 118.25 | 118.25 |
| Standard Deviation | 8.65 | 8.65 | 8.65 | 8.65 |
| Date of Most Recent Estimate | 05/31/18 | 05/11/18 | 05/11/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K/A | Amendment to a previously filed 8-K | 33 | 2018-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-06-14 |
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-24 |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 9 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 5 | 6 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.92 | 1.92 | 1.77 | 1.8 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
